Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection

This study has been completed.
Sponsor:
Collaborator:
Janssen Pharmaceuticals
Information provided by (Responsible Party):
Michelle Floris-Moore, MD, University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier:
NCT00959894
First received: August 14, 2009
Last updated: July 11, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2014
  Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)